Pasithea Therapeutics Corp. (KTTAW) Long-Term Debt Issuances (2021 - 2025)
Pasithea Therapeutics' (KTTAW) quarterly Long-Term Debt Issuances came in at $179310.0 in Q1 2025, down 54.3% quarter-over-quarter from $392354.0 in Q1 2023.
Analysis
Pasithea Therapeutics Corp. (KTTAW) Long-Term Debt Issuances (2021 - 2025) Analysis & Trends
Pasithea Therapeutics has disclosed Long-Term Debt Issuances across 3 years of filings, most recently posting $179310.0 for Q1 2025.
- In Q1 2025, Long-Term Debt Issuances changed N/A year-over-year to $179310.0; the TTM figure through Mar 2025 stood at $179310.0 (changed N/A YoY), while the FY2023 annual figure was $392354.0, changed N/A from the prior year.
- Long-Term Debt Issuances came in at $179310.0 for Q1 2025 at Pasithea Therapeutics, down from $392354.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $20.7 million in Q3 2021 to a low of $179310.0 in Q1 2025.
- Average Long-Term Debt Issuances over 3 years is $5.5 million, with a median of $1.2 million recorded in 2021.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 179,310.00 |
| Mar 31, 2023 | 392,354.00 |
| Dec 31, 2021 | 5.30 Mn |
| Sep 30, 2021 | 20.65 Mn |
| Mar 31, 2021 | 1.21 Mn |